TScan Therapeutics, Inc. (TCRX) Reports Q1 2026 Results With Improved Net Loss
TheFly reported on May 6 that TCRX announced its first-quarter 2026 financial results, covering the period ended March 31, 2026, along with a corporate update.
Tscan Therapeutics Inc. (TCRX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lynx1 Capital Management Weston Nichols | 8,019,148 | $7,859,567 | 0.91% | |
| 2. | Biotechnology Value Fund / BVF Inc Mark Lampert | 5,564,290 | $5,453,561 | 0.14% | |
| 3. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,784,792 | $2,729,375 | 0.01% | |
| 4. | Renaissance Technologies Jim Simons | 1,326,799 | $1,300,396 | -3% | 0% |
| 5. | Millennium Management Israel Englander | 1,163,611 | $1,140,455 | -21% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.90 | 6,232 | $5,601.94 | 8,019,148 | 2025-12-23 | Filing | |
| $0.90 | 75,500 | $67,950.00 | 8,012,916 | 2025-12-22 | Filing | |
| $0.90 | 80,069 | $71,974.02 | 7,937,416 | 2025-12-19 | Filing | |
| $1.20 | 1,200,000 | $1,440,000.00 | 7,946,141 | 2025-05-20 | Filing | |
| $1.20 | 1,388,794 | $1,666,552.80 | 6,746,141 | 2025-05-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.78 | 164,686 | $952,115.64 | 4,716 | 2024-08-23 | Filing | |
| $2.51 | 400 | $1,003.00 | 5,224,600 | 2023-05-31 | Filing | |
| $2.52 | 15,000 | $37,801.50 | 5,225,000 | 2023-05-31 | Filing | |
| $2.51 | 10,000 | $25,148.00 | 5,240,000 | 2023-05-31 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,158,831 | $2,115,654 | 0% | |
| 2. | 994,654 | $974,860 | 0% | |
| 3. | 584,811 | $573,401 | 0% | |
| 4. | 363,954 | $356,675 | 0% | |
| 5. | 207,313 | $203,187 | 0% |
News See All
10 Popular Penny Stocks on Robinhood to Watch in 2026
Penny stocks remain one of the market’s most debated investment areas, offering the potential for enormous gains while carrying equally significant risks.
Strong Analyst Sentiment on TScan Therapeutics (TCRX) Amid Ongoing Momentum in Cell Therapy Space
As of March 19, 2026, analysts maintain a strong sentiment regarding TScan Therapeutics, Inc. (TCRX).
Top 10 Stocks Under $5 That Could Triple
At one end of the spectrum, until a few weeks ago, there was optimism about the broader market's performance this year.
Chinese Billionaire Zhang Lei is Selling These 10 Stocks
In this article, we present the list of the 1o stocks that billionaire Zhang Lei is selling off.
Hedge Fund and Insider Trading News: Howard Marks, Ray Dalio, Eisler Capital, King Street Capital Management, SkyBridge Capital, Ault Global Holdings Inc (DPW), BioVaxys Technology (BVAXF), and More
Eisler Capital, one of Europe’s most secretive hedge funds, has raised about $1 billion for a new money pool that plans to use leveraged bets to juice its track record of reliable single-digit returns...
Hedge Fund Resource Center